Latest Insider Transactions at Regeneron Pharmaceuticals, Inc. (REGN)
This section provides a real-time view of insider transactions for Regeneron Pharmaceuticals, Inc. (REGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REGENERON PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REGENERON PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 06
2020
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
2,000
-20.74%
|
$1,120,000
$560.0 P/Share
|
|
May 06
2020
|
Arthur F Ryan Director |
SELL
Bona fide gift
|
Direct |
2,000
-7.59%
|
-
|
|
May 01
2020
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$52,200
$522.39 P/Share
|
|
Apr 20
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
5,300
-2.54%
|
$3,005,100
$567.48 P/Share
|
|
Apr 20
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
3,250
-1.12%
|
$1,842,750
$567.79 P/Share
|
|
Apr 17
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
6,322
-14.61%
|
$3,508,710
$555.82 P/Share
|
|
Apr 17
2020
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Exercise of conversion of derivative security
|
Direct |
11,622
+21.07%
|
$685,698
$59.2 P/Share
|
|
Apr 17
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
2,267
-0.81%
|
$1,258,185
$555.4 P/Share
|
|
Apr 17
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,250
-25.09%
|
$5,133,750
$555.82 P/Share
|
|
Apr 17
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+25.32%
|
$3,400,000
$272.7 P/Share
|
|
Apr 17
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
991
-0.28%
|
$550,005
$555.42 P/Share
|
|
Apr 16
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
2,733
-14.06%
|
$1,445,757
$529.79 P/Share
|
|
Apr 16
2020
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.46%
|
$295,000
$59.2 P/Share
|
|
Apr 16
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,009
-10.61%
|
$1,591,761
$529.79 P/Share
|
|
Apr 16
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+12.36%
|
$1,088,000
$272.7 P/Share
|
|
Apr 15
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
853
-0.57%
|
$442,707
$519.71 P/Share
|
|
Apr 15
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
2,262
-1.44%
|
$1,173,978
$519.4 P/Share
|
|
Apr 14
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,647
-9.5%
|
$1,379,087
$521.45 P/Share
|
|
Apr 14
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+11.16%
|
$952,000
$272.7 P/Share
|
|
Apr 14
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
2,738
-14.09%
|
$1,426,498
$521.45 P/Share
|
|
Apr 14
2020
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.46%
|
$295,000
$59.2 P/Share
|
|
Apr 14
2020
|
Neil Stahl EVP Research and Development |
SELL
Open market or private sale
|
Direct |
5,497
-5.36%
|
$2,858,440
$520.68 P/Share
|
|
Apr 13
2020
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
7,582
-31.0%
|
$3,874,402
$511.56 P/Share
|
|
Apr 13
2020
|
Neil Stahl EVP Research and Development |
BUY
Exercise of conversion of derivative security
|
Direct |
13,079
+34.84%
|
$680,108
$52.03 P/Share
|
|
Apr 13
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
828
-0.37%
|
$421,452
$509.95 P/Share
|
|
Apr 09
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,672
-9.59%
|
$1,357,376
$508.25 P/Share
|
|
Apr 09
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+11.16%
|
$952,000
$272.7 P/Share
|
|
Apr 07
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
696
-1.39%
|
$348,000
$500.15 P/Share
|
|
Apr 06
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,304
-8.42%
|
$1,149,696
$499.95 P/Share
|
|
Apr 06
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+9.88%
|
$816,000
$272.7 P/Share
|
|
Apr 03
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
683
-0.28%
|
$337,402
$494.85 P/Share
|
|
Apr 02
2020
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
433
-0.3%
|
-
|
|
Apr 02
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
6,797
-2.7%
|
$3,330,530
$490.97 P/Share
|
|
Apr 02
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
1,353
-0.35%
|
$662,970
$490.51 P/Share
|
|
Apr 02
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,317
-8.07%
|
$1,139,964
$492.05 P/Share
|
|
Apr 02
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+9.46%
|
$816,000
$272.7 P/Share
|
|
Apr 01
2020
|
Christopher R. Fenimore VP Controller |
SELL
Open market or private sale
|
Direct |
1,200
-0.67%
|
$584,400
$487.35 P/Share
|
|
Apr 01
2020
|
Christopher R. Fenimore VP Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,200
+7.74%
|
$36,000
$30.63 P/Share
|
|
Apr 01
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
8,203
-12.71%
|
$4,003,064
$488.22 P/Share
|
|
Apr 01
2020
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+18.83%
|
$885,000
$59.2 P/Share
|
|
Apr 01
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,647
-5.76%
|
$2,267,736
$488.21 P/Share
|
|
Apr 01
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+6.9%
|
$1,632,000
$272.7 P/Share
|
|
Apr 01
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
600
-0.24%
|
$291,600
$486.54 P/Share
|
|
Apr 01
2020
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.02%
|
$48,600
$486.06 P/Share
|
|
Mar 30
2020
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.04%
|
$46,500
$465.94 P/Share
|
|
Mar 10
2020
|
George Yancopoulos President and Chief Scientific |
SELL
Open market or private sale
|
Direct |
117,815
-0.81%
|
$55,726,495
$473.68 P/Share
|
|
Mar 09
2020
|
George Yancopoulos President and Chief Scientific |
SELL
Payment of exercise price or tax liability
|
Direct |
128,921
-9.6%
|
$61,366,396
$476.42 P/Share
|
|
Mar 09
2020
|
George Yancopoulos President and Chief Scientific |
BUY
Exercise of conversion of derivative security
|
Direct |
246,736
+15.48%
|
$7,402,080
$30.63 P/Share
|
|
Mar 09
2020
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
2,000
-2.06%
|
$948,000
$474.28 P/Share
|
|
Mar 09
2020
|
Joseph L Goldstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+14.66%
|
$66,000
$33.42 P/Share
|